MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
9.41
-0.53 (-5.33%)
Oct 16, 2026, 4:00 PM EDT - Market closed
MiNK Therapeutics Employees
MiNK Therapeutics had 15 employees as of December 31, 2025. The number of employees decreased by 8 or -34.78% compared to the previous year. That makes MiNK Therapeutics the 39,134th largest employer in the world and 5,707th in the United States.
Employees
15
Change (1Y)
-8
Growth (1Y)
-34.78%
Revenue / Employee
n/a
Profits / Employee
-$757,359
Market Cap
48.02M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 15 | -8 | -34.78% |
| Dec 31, 2024 | 23 | -8 | -25.81% |
| Dec 31, 2023 | 31 | -6 | -16.22% |
| Dec 31, 2022 | 37 | 4 | 12.12% |
| Dec 31, 2021 | 33 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Adicet Bio | 102 |
| Caribou Biosciences | 97 |
| Mereo BioPharma Group | 39 |
| iBio, Inc. | 23 |
| LeonaBio | 19 |
| ImageneBio | 18 |
| Werewolf Therapeutics | 14 |
| Apollomics | 14 |
INKT News
- 6 days ago - MiNK Therapeutics management to meet virtually with B. Riley - TheFly
- 6 days ago - MiNK Therapeutics management to meet virtually with B. Riley - TheFly
- 6 days ago - MiNK Therapeutics management to meet virtually with B. Riley - TheFly
- 16 days ago - MiNK Therapeutics to present data on cancer research at SITC 2026 - TheFly
- 16 days ago - MiNK Therapeutics to Present Data on Treatment-Resistant Colorectal Cancer and Clearance of Senescent Tumor Cells and Fibroblasts at SITC 2026 - GlobeNewsWire
- 18 days ago - MiNK selected for ARPA-H-Funded initiative to advance room-temp cell therapy - TheFly
- 18 days ago - MiNK Therapeutics Selected for ARPA-H-Funded Initiative to Advance Room-Temperature Cell Therapy - GlobeNewsWire
- 2 months ago - MiNK Therapeutics Earnings Call Transcript: Q2 2026 - Transcripts